Breast	B-Cancer
cancer	I-Cancer

The	O
incidence	O
of	O
breast	B-Cancer
cancer	I-Cancer
is	O
no	O
higher	O
than	O
in	O
the	O
rest	O
of	O
the	O
population	O
.	O

Tamoxifen	O
should	O
not	O
be	O
used	O
as	O
it	O
may	O
worsen	O
symptoms	O
[	O
43	O
]	O
.	O

Women	O
need	O
also	O
specific	O
management	O
for	O
treatment	O
of	O
HAE	O
.	O

Short	O
term	O
prophylaxis	O
:	O
three	O
options	O
are	O
available	O
:	O
attenuated	O
androgens	O
,	O
tranexamic	O
acid	O
or	O
C1Inh	O
concentrate	O
.	O

There	O
is	O
no	O
specific	O
problem	O
for	O
the	O
use	O
of	O
theses	O
drugs	O
for	O
short	O
course	O
in	O
female	O
patients	O
.	O

In	O
case	O
of	O
short	O
term	O
prophylaxis	O
with	O
attenuated	O
androgens	O
,	O
no	O
virilisation	O
has	O
been	O
observed	O
[	O
44	O
,	O
45	O
]	O
.	O

Acute	O
attack	O
treatment	O
:	O
there	O
is	O
no	O
specific	O
problem	O
for	O
the	O
use	O
of	O
C1inh	O
concentrate	O
,	O
tranexamic	O
acid	O
,	O
icatibant	O
;	O
or	O
ecallantide	O
in	O
female	O
patients	O
.	O

